UBS Group’s Sigma Labs, Inc. Warrant SGLBW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-31,294
| Closed | -$1K | – | 11530 |
|
|
2021
Q4 | $1K | Buy |
31,294
+22,955
| +275% | +$3.12K | ﹤0.01% | 10196 |
|
|
2021
Q3 | $2K | Buy |
8,339
+6,014
| +259% | +$1.45K | ﹤0.01% | 9102 |
|
|
2021
Q2 | $1K | Buy |
2,325
+3
| +0.1% | +$1 | ﹤0.01% | 9311 |
|
|
2021
Q1 | $1K | Sell |
2,322
-233
| -9% | -$105 | ﹤0.01% | 8875 |
|
|
2020
Q4 | $1K | Sell |
2,555
-3,518
| -58% | -$655 | ﹤0.01% | 8305 |
|
|
2020
Q3 | $1K | Sell |
6,073
-2,400
| -28% | -$465 | ﹤0.01% | 7893 |
|
|
2020
Q2 | $2K | Buy |
8,473
+6,185
| +270% | +$970 | ﹤0.01% | 7702 |
|
|
2020
Q1 | $0 | Buy |
2,288
+1,490
| +187% | +$551 | ﹤0.01% | 8621 |
|
|
2019
Q4 | $0 | Sell |
798
-1,200
| -60% | -$590 | ﹤0.01% | 8569 |
|
|
2019
Q3 | $0 | Sell |
1,998
-7
| -0.3% | -$2 | ﹤0.01% | 8406 |
|
|
2019
Q2 | $1K | Hold |
2,005
| – | – | ﹤0.01% | 7768 |
|
|
2019
Q1 | $1K | Sell |
2,005
-1,300
| -39% | -$891 | ﹤0.01% | 7604 |
|
|
2018
Q4 | $1K | Sell |
3,305
-100
| -3% | -$39 | ﹤0.01% | 7939 |
|
|
2018
Q3 | $1K | Hold |
3,405
| – | – | ﹤0.01% | 7883 |
|
|
2018
Q2 | $1K | Sell |
3,405
-500
| -13% | -$235 | ﹤0.01% | 7870 |
|
|
2018
Q1 | $1K | Buy |
3,905
+349
| +10% | +$145 | ﹤0.01% | 7689 |
|
|
2017
Q4 | $2K | Buy |
+3,556
| New | +$1.59K | ﹤0.01% | 7652 |
|
UBS Group's SGLBW Position: Q1 2022 in Review
UBS Group sold out of Sigma Labs, Inc. Warrant (SGLBW) in Q1 2022, closing a stake of 31,294 shares — an estimated $1K sold.
UBS Group first reported a position in SGLBW in Q4 2017 and held it in 17 quarters. The position peaked at $2K in Q3 2021. 0 funds tracked by Wall St. Rank hold SGLBW as of Q1 2022.
- UBS Group reported no remaining Sigma Labs, Inc. Warrant position as of Q1 2022 after selling out during the quarter.
- UBS Group sold 31,294 Sigma Labs, Inc. Warrant shares in Q1 2022, an estimated $1K.
- UBS Group first reported a position in Sigma Labs, Inc. Warrant in Q4 2017 and held it in 17 quarters.
- UBS Group's Sigma Labs, Inc. Warrant position peaked at $2K in Q3 2021.
- 0 funds tracked by Wall St. Rank held Sigma Labs, Inc. Warrant as of Q1 2022.
Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.